News | Artificial Intelligence | October 08, 2019

RSNA Announces Intracranial Hemorrhage AI Challenge

Competitors will use data set of more than 25,000 head CT scans to develop artificial intelligence algorithms to detect intracranial hemorrhage

RSNA Announces Intracranial Hemorrhage AI Challenge

October 8, 2019 — The Radiological Society of North America (RSNA) recently launched its third annual artificial intelligence (AI) challenge: the RSNA Intracranial Hemorrhage Detection and Classification Challenge.

The AI Challenge is a competition among researchers to create applications that perform a defined task according to specified performance measures. Last year’s pneumonia detection challenge had more than 1,400 teams.

“The goal of an AI challenge is to explore and demonstrate the ways AI can benefit radiology and improve clinical diagnostics,” said Luciano Prevedello, M.D., MPH, chair of the Machine Learning Steering Subcommittee of the RSNA Radiology Informatics Committee. “By organizing these data challenges, RSNA plays a critical role in demonstrating the capabilities of machine learning and fostering the development of AI in improving patient care.”

This year, researchers are working to develop algorithms that can identify and classify subtypes of hemorrhages on head computed tomography (CT) scans. The data set, which comprises more than 25,000 head CT scans contributed by several research institutions, is the first multiplanar dataset used in an RSNA AI Challenge.

The Machine Learning Steering Subcommittee worked with volunteer specialists from the American Society of Neuroradiology (ASNR) to label these exams for the presence of five subtypes of intracranial hemorrhage — an effort of unprecedented scope in the radiology community, the association said.

The challenge is being run on a platform provided by Kaggle Inc. (a subsidiary of Alphabet Inc., also the parent company of Google). Kaggle has recognized the RSNA Intracranial Hemorrhage Detection and Classification Challenge as a public good and will award $25,000 to the winning entries.

On Sept. 3, 2019, the first wave of data was released to researchers who are working to develop and “train” algorithms. The training phase runs through Nov. 4. During this phase, participants will use a training dataset that includes the radiologists’ labels to develop algorithms that replicate those annotations.

During the evaluation phase, from Nov. 4 to Nov. 11, participants will apply their algorithms to the testing portion of the dataset, which is provided to them with the annotations withheld.

Their results will then be compared to the annotations on the testing dataset, and an evaluation metric will be applied to rate their accuracy and determine the winners.

Results will be announced in November and the top submissions will be recognized in the AI Showcase Theater during the RSNA 2019 annual meeting, Dec. 1-6, in Chicago. 

For more information:

Related Content

The FDA clearance, Quantib’s 6th to date, marks the first time a comprehensive AI prostate solution will be available to radiologists in the United States
News | Prostate Cancer | October 21, 2020
October 21, 2020 — Quantib, a market leader in...
According to an inquest, a man with a heart disorder and chest pain died two days after a doctor viewed the wrong scan and sent him home
News | Computed Tomography (CT) | October 21, 2020
October 21, 2020 — The BBC News
Flowchart of patient inclusion and exclusion.

Figure 1. Flowchart of patient inclusion and exclusion.

News | Coronavirus (COVID-19) | October 20, 2020
October 20, 2020 — A new multi-institutional study published in the journal ...
Rensselaer, First-Imaging, and GE Global researchers develop a deep neural network to perform nearly as well as more complex dual-energy CT imaging technology
News | Computed Tomography (CT) | October 20, 2020
October 20, 2020 — Bioimaging technologies are the eyes that allow doctors to see inside the body in order to diagnos
Ezra, a NY-based startup transforming early cancer screening using magnetic resonance imaging (MRI), announced that it has received FDA 510(k) premarket authorization for its Artificial Intelligence, designed to decrease the cost of MRI-based cancer screening, assisting radiologists in their analysis of prostate MRI scans. It is the first prostate AI to be cleared by the FDA.
News | Artificial Intelligence | October 20, 2020
October 20, 2020 — Ezra, a NY-based startup transforming early cancer screening using...
Carestream Health will offer insights on technology, innovative new products and research in medical imaging through a new webinar series titled Carestream Talks. #RSNA20
News | Radiology Education | October 14, 2020
October 14, 2020 — Carestrea